舒利迭联合标准桃金娘油治疗AECOPD的疗效观察

A study to assess the effects of Seretide combined with myrotol standardized on patients with AECOPD

目的探讨沙美特罗氟替卡松(舒利迭)联合标准桃金娘油在慢性阻塞性肺疾病急性期(AECOPD)的临床疗效。方法 40患者随机分为对照组和治疗组(舒利迭加标准桃金娘油)各20例。两组入院期间均给于常规抗感染、吸氧和平喘对症治疗,试验组加用舒利迭和标准桃金娘油,共随访观察2周,观察2组患者的症状及血气改善情况、肺功能情况并分析。结果治疗组(舒利迭加标准桃金娘油)在临床效果,祛痰作用和综合临床评价等方面都较治疗前明显改善(P<0.05)。结论舒利迭和标准桃金娘油共同作用对AECOPD患者疗效确切,使用安全,值得临床常规使用。

Objective To explore the effects of combining seretide and myrtol standardized on patients with AECOPD. Methods 40 patients with AECOPD were randomly divided into two groups： experimental group（20 cases） and control group （20 cases） . The basic treatments for the two groups were antibiotics,oxygens in-halation and antiasthma etc. The experimental group was given seretide and myrtol standardized. The experiment lasted for two weeks to observe and evaluate difference between the two groups in clinical symptoms,blood gas analysis and lung function. Results The expecorant action and comprehensive clinical evalution in experimen-tal group was better than control group,there was significant difference between two groups （P〈0.05） . Con-clusion The effects of combining seretide and myrtol standardized on patients with AECOPD is definite.